112 related articles for article (PubMed ID: 19954850)
1. Junctional diversity prevents negative selection of an antigen-specific T cell repertoire.
Kilgannon P; Novak Z; Fotedar A; Singh B
Mol Immunol; 2010 Feb; 47(5):1154-60. PubMed ID: 19954850
[TBL] [Abstract][Full Text] [Related]
2. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H
Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418
[TBL] [Abstract][Full Text] [Related]
3. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
Simpson E; Takacs K; Altmann DM
Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the Mlsf system. II. Identification of mouse mammary tumor virus proviruses involved in the clonal deletion of self-Mlsf-reactive T cells.
Foo-Phillips M; Kozak CA; Principato MA; Abe R
J Immunol; 1992 Dec; 149(11):3440-7. PubMed ID: 1331236
[TBL] [Abstract][Full Text] [Related]
5. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
[TBL] [Abstract][Full Text] [Related]
6. Identification of an endogenous mammary tumor virus involved in the clonal deletion of V beta 2 T cells.
Jouvin-Marche E; Marche PN; Six A; Liebe-Gris C; Voegtle D; Cazenave PA
Eur J Immunol; 1993 Nov; 23(11):2758-64. PubMed ID: 8223851
[TBL] [Abstract][Full Text] [Related]
7. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice.
Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
Eur J Immunol; 1994 Jul; 24(7):1612-9. PubMed ID: 7913038
[TBL] [Abstract][Full Text] [Related]
8. Receptors on T cells escaping superantigen-mediated deletion lack special beta-chain junctional region structural characteristics.
Pullen AM; Bogatzki LY
J Immunol; 1996 Mar; 156(5):1865-72. PubMed ID: 8596038
[TBL] [Abstract][Full Text] [Related]
9. Nonspecific augmentation of lymph node T cells and I-E-independent selective deletion of V beta 14+ T cells by Mtv-2 in the DDD mouse.
Nakano H; Yoshimoto T; Kakiuchi T; Matsuzawa A
Eur J Immunol; 1993 Oct; 23(10):2434-9. PubMed ID: 8405042
[TBL] [Abstract][Full Text] [Related]
10. Expression and presentation of endogenous mouse mammary tumor virus superantigens by thymic and splenic dendritic cells and B cells.
Ardavín C; Waanders G; Ferrero I; Anjuère F; Acha-Orbea H; MacDonald HR
J Immunol; 1996 Oct; 157(7):2789-94. PubMed ID: 8816381
[TBL] [Abstract][Full Text] [Related]
11. T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity.
Papiernik M; do Carmo Leite-de-MoraesM ; Pontoux C; Joret AM; Rocha B; Penit C; Dy M
J Immunol; 1997 May; 158(10):4642-53. PubMed ID: 9144476
[TBL] [Abstract][Full Text] [Related]
12. Deletion of peripheral V beta 14+ T cells by Mtv-2-encoded viral superantigen preceded by blastogenesis and DNA synthesis but not by specific expansion.
Nakano H; Yoshimoto T; Nariuchi H; Kakiuchi T; Matsuzawa A
Cell Immunol; 1996 Mar; 168(2):281-90. PubMed ID: 8640876
[TBL] [Abstract][Full Text] [Related]
13. Differences in the avidity of TCR interactions with a superantigenic ligand affect negative selection but do not allow positive selection.
Chervonsky AV; Golovkina TV; Ross SR; Janeway CA
J Immunol; 1995 Dec; 155(11):5115-23. PubMed ID: 7594520
[TBL] [Abstract][Full Text] [Related]
14. Expression of two structurally identical viral superantigens results in thymic elimination at distinct developmental stages.
Morishima C; Norby-Slycord C; McConnell KR; Finch RJ; Nelson AJ; Farr AG; Pullen AM
J Immunol; 1994 Dec; 153(11):5091-103. PubMed ID: 7963568
[TBL] [Abstract][Full Text] [Related]
15. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
Hodes RJ; Novick MB; Palmer LD; Knepper JE
J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408
[TBL] [Abstract][Full Text] [Related]
16. A maternally-inherited alteration in the T cell repertoire of BALB/c mice.
Goldman A; Buggiano V; Franco M; Déroche A; Nepomnaschy I; Piazzon I
Medicina (B Aires); 1995; 55(1):45-7. PubMed ID: 7565035
[TBL] [Abstract][Full Text] [Related]
17. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB).
Luther S; Shakhov AN; Xenarios I; Haga S; Imai S; Acha-Orbea H
Eur J Immunol; 1994 Aug; 24(8):1757-64. PubMed ID: 8056034
[TBL] [Abstract][Full Text] [Related]
18. V beta repertoire of murine hepatic T cells. Implication for selection of double negative alpha beta + T cells.
Seki S; Kono DH; Balderas RS; Theofilopoulos AN
J Immunol; 1994 Jul; 153(2):637-46. PubMed ID: 8021501
[TBL] [Abstract][Full Text] [Related]
19. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice.
Gill R; Wang H; Bluethmann H; Iglesias A; Wei WZ
Cancer Res; 1994 Mar; 54(6):1529-35. PubMed ID: 8137259
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of superantigen recognition by peptides of the variable region of the T cell receptor beta chain.
MacNeil D; Fraga E; Singh B
Eur J Immunol; 1992 Apr; 22(4):937-41. PubMed ID: 1532364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
